Published in Synapse on October 01, 2010
Methamphetamine influences on brain and behavior: unsafe at any speed? Trends Neurosci (2012) 0.96
Dorsal striatal dopamine depletion impairs both allocentric and egocentric navigation in rats. Neurobiol Learn Mem (2012) 0.89
Comparison of (+)-methamphetamine, ±-methylenedioxymethamphetamine, (+)-amphetamine and ±-fenfluramine in rats on egocentric learning in the Cincinnati water maze. Synapse (2010) 0.86
Nucleus accumbens invulnerability to methamphetamine neurotoxicity. ILAR J (2011) 0.82
Long-term effects of exposure to methamphetamine in adolescent rats. Drug Alcohol Depend (2014) 0.82
Prior methamphetamine self-administration attenuates serotonergic deficits induced by subsequent high-dose methamphetamine administrations. Drug Alcohol Depend (2012) 0.81
The role of the GABA system in amphetamine-type stimulant use disorders. Front Cell Neurosci (2015) 0.77
Cincinnati water maze: A review of the development, methods, and evidence as a test of egocentric learning and memory. Neurotoxicol Teratol (2016) 0.76
Path integration and the neural basis of the 'cognitive map'. Nat Rev Neurosci (2006) 7.33
Conjunctive representation of position, direction, and velocity in entorhinal cortex. Science (2006) 6.81
The neurobiology of stress: from serendipity to clinical relevance. Brain Res (2000) 4.51
A spin glass model of path integration in rat medial entorhinal cortex. J Neurosci (2006) 4.31
Impaired recognition memory in rats after damage to the hippocampus. J Neurosci (2000) 4.07
Laboratory routines cause animal stress. Contemp Top Lab Anim Sci (2004) 3.91
The acute effects of corticosteroids on cognition: integration of animal and human model studies. Brain Res Brain Res Rev (1997) 2.88
Neuroendocrine pharmacology of stress. Eur J Pharmacol (2003) 2.77
Maturation of the adrenocortical stress response: neuroendocrine control mechanisms and the stress hyporesponsive period. Brain Res (1986) 2.73
Reorganization of the morphology of hippocampal neurites and synapses after stress-induced damage correlates with behavioral improvement. Neuroscience (2000) 2.54
Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction (2007) 2.49
The need for speed: an update on methamphetamine addiction. J Psychiatry Neurosci (2006) 2.46
Functions of frontostriatal systems in cognition: comparative neuropsychopharmacological studies in rats, monkeys and humans. Biol Psychol (2006) 2.36
Implications of chronic methamphetamine use: a literature review. Harv Rev Psychiatry (2005) 1.94
Stress, Glucocorticoids, and Damage to the Nervous System: The Current State of Confusion. Stress (1996) 1.70
Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J Pharmacol Exp Ther (1994) 1.63
Spatial representation and the architecture of the entorhinal cortex. Trends Neurosci (2006) 1.55
The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity. J Neurochem (2007) 1.37
Neurotoxic methamphetamine regimen severely impairs recognition memory in rats. Synapse (2003) 1.29
Corticolimbic dysregulation and chronic methamphetamine abuse. Addiction (2007) 1.28
Memory retrieval impairment induced by hippocampal CA3 lesions is blocked by adrenocortical suppression. Nat Neurosci (2001) 1.27
Refining the critical period for methamphetamine-induced spatial deficits in the Morris water maze. Psychopharmacology (Berl) (2003) 1.26
Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents. J Pharmacol Exp Ther (1995) 1.26
The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J Pharmacol Exp Ther (1992) 1.23
Long-term monoamine depletion, differential recovery, and subtle behavioral impairment following methamphetamine-induced neurotoxicity. Pharmacol Biochem Behav (1998) 1.23
Impaired object recognition memory following methamphetamine, but not p-chloroamphetamine- or d-amphetamine-induced neurotoxicity. Neuropsychopharmacology (2005) 1.21
Caudate nucleus and memory for egocentric localization. Behav Neural Biol (1988) 1.21
Hippocampal lesions and path integration. Curr Opin Neurobiol (1997) 1.18
Methamphetamine influences on recognition memory: comparison of escalating and single-day dosing regimens. Neuropsychopharmacology (2007) 1.17
Impaired sequential egocentric and allocentric memories in forebrain-specific-NMDA receptor knock-out mice during a new task dissociating strategies of navigation. J Neurosci (2006) 1.16
Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice. Brain Res (1994) 1.13
The caudate nucleus egocentric localization system. Acta Neurobiol Exp (Wars) (1972) 1.12
Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine. J Pharmacol Exp Ther (2001) 1.11
Serotonin and human cognitive performance. Curr Pharm Des (2006) 1.11
Effect of +-methamphetamine on path integration learning, novel object recognition, and neurotoxicity in rats. Psychopharmacology (Berl) (2008) 1.10
3,4-Methylenedioxymethamphetamine in adult rats produces deficits in path integration and spatial reference memory. Biol Psychiatry (2005) 1.06
Short toxic methamphetamine schedule impairs object recognition task in male rats. Brain Res (2002) 1.05
Ontogeny of methamphetamine-induced neurotoxicity and associated hyperthermic response. Brain Res Dev Brain Res (1997) 1.01
Relation between methamphetamine-induced monoamine depletions in the striatum and sequential motor learning. Pharmacol Biochem Behav (2005) 1.01
Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation. From obesity to memory deficits. Mol Neurobiol (1998) 1.01
Euthanasia by decapitation: evidence that this technique produces prompt, painless unconsciousness in laboratory rodents. Neurotoxicol Teratol (1992) 0.99
A sensitizing regimen of methamphetamine causes impairments in a novelty preference task of object recognition. Behav Brain Res (2006) 0.99
Methamphetamine-induced neural and cognitive changes in rodents. Addiction (2007) 0.99
Alterations in body temperature, corticosterone, and behavior following the administration of 5-methoxy-diisopropyltryptamine ('foxy') to adult rats: a new drug of abuse. Neuropsychopharmacology (2006) 0.98
Effects of neonatal (+)-methamphetamine on path integration and spatial learning in rats: effects of dose and rearing conditions. Int J Dev Neurosci (2008) 0.98
The effects of chronic administration of quetiapine on the methamphetamine-induced recognition memory impairment and dopaminergic terminal deficit in rats. Behav Brain Res (2006) 0.93
Elevated basal trough levels of corticosterone suppress hippocampal 5-hydroxytryptamine(1A) receptor expression in adrenally intact rats: implication for the pathogenesis of depression. Neuroscience (1997) 0.92
Persistent anxiogenic effects of a single or repeated doses of cocaine and methamphetamine: interactions with endogenous cannabinoid receptor ligands. Behav Pharmacol (2005) 0.90
Sympatho-adrenal involvement in methamphetamine-induced hyperthermia through skeletal muscle hypermetabolism. Eur J Pharmacol (1998) 0.90
Procedure of rectal temperature measurement affects brain, muscle, skin, and body temperatures and modulates the effects of intravenous cocaine. Brain Res (2007) 0.89
Administration of D,L-fenfluramine to rats produces learning deficits in the Cincinnati water maze but not the Morris water maze: relationship to adrenal cortical output. Neurotoxicol Teratol (2002) 0.89
Effects of vibrissae removal on methamphetamine-induced damage to rat somatosensory cortical neurons. Synapse (2002) 0.86
Metyrapone attenuates the sequential learning deficits but not monoamine depletions following d,l-fenfluramine administration to adult rats. Synapse (2004) 0.85
The involvement of serotonin in regulation of pituitary-adrenocortical function. Front Neuroendocrinol (1992) 0.85
Escalating dose, multiple binge methamphetamine regimen does not impair recognition memory in rats. Synapse (2007) 0.83
Iboga compounds reverse the behavioural disinhibiting and corticosterone effects of acute methamphetamine: Implications for their antiaddictive properties. Pharmacol Biochem Behav (2001) 0.83
Evidence for ACTH-unrelated mechanisms in the regulation of cortisol secretion in man. Klin Wochenschr (1984) 0.81
Metyrapone displays antidepressant-like properties in preclinical paradigms. Psychopharmacology (Berl) (1999) 0.79
Age-dependent loss of corticosterone modulation of central serotonin 5-HT1A receptor binding sites. J Neurosci Res (1998) 0.77
Chronic administration of quetiapine alleviates the anxiety-like behavioural changes induced by a neurotoxic regimen of dl-amphetamine in rats. Behav Brain Res (2004) 0.76
Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc (2006) 7.64
Cerebral ischemia-hypoxia induces intravascular coagulation and autophagy. Am J Pathol (2006) 3.18
Serotonin regulates mammary gland development via an autocrine-paracrine loop. Dev Cell (2004) 2.40
Hypoxia-ischemia induces DNA synthesis without cell proliferation in dying neurons in adult rodent brain. J Neurosci (2004) 1.94
The effects of neonatal isoflurane exposure in mice on brain cell viability, adult behavior, learning, and memory. Anesth Analg (2009) 1.78
Deficiency in Na,K-ATPase alpha isoform genes alters spatial learning, motor activity, and anxiety in mice. J Neurosci (2007) 1.70
Amphetamine toxicities: classical and emerging mechanisms. Ann N Y Acad Sci (2010) 1.62
Exposure to 3,4-methylenedioxymethamphetamine (MDMA) on postnatal days 11-20 induces reference but not working memory deficits in the Morris water maze in rats: implications of prior learning. Int J Dev Neurosci (2004) 1.28
Refining the critical period for methamphetamine-induced spatial deficits in the Morris water maze. Psychopharmacology (Berl) (2003) 1.26
Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits. Hum Mol Genet (2010) 1.25
Methamphetamine exposure from postnatal day 11 to 20 causes impairments in both behavioral strategies and spatial learning in adult rats. Brain Res (2002) 1.24
Developmental 3,4-methylenedioxymethamphetamine (MDMA) impairs sequential and spatial but not cued learning independent of growth, litter effects or injection stress. Brain Res (2003) 1.24
Protecting children from environmental toxins. PLoS Med (2005) 1.23
Developmental D-methamphetamine treatment selectively induces spatial navigation impairments in reference memory in the Morris water maze while sparing working memory. Synapse (2003) 1.20
Effect of +-methamphetamine on path integration learning, novel object recognition, and neurotoxicity in rats. Psychopharmacology (Berl) (2008) 1.10
Developmental effects of 3,4-methylenedioxymethamphetamine: a review. Behav Pharmacol (2008) 1.10
Long-term effects of neonatal methamphetamine exposure in rats on spatial learning in the Barnes maze and on cliff avoidance, corticosterone release, and neurotoxicity in adulthood. Brain Res Dev Brain Res (2003) 1.10
Abnormal neurodevelopment, neurosignaling and behaviour in Npas3-deficient mice. Eur J Neurosci (2005) 1.09
Na,K-ATPase and the role of alpha isoforms in behavior. J Bioenerg Biomembr (2007) 1.07
3,4-Methylenedioxymethamphetamine in adult rats produces deficits in path integration and spatial reference memory. Biol Psychiatry (2005) 1.06
Creatine transporter (CrT; Slc6a8) knockout mice as a model of human CrT deficiency. PLoS One (2011) 1.06
Progression of multiple behavioral deficits with various ages of onset in a murine model of Hurler syndrome. Brain Res (2007) 1.05
Assessing spatial learning and memory in rodents. ILAR J (2014) 1.04
Comparison of the elevated plus and elevated zero mazes in treated and untreated male Sprague-Dawley rats: effects of anxiolytic and anxiogenic agents. Pharmacol Biochem Behav (2010) 1.04
Behavioral and growth effects induced by low dose methamphetamine administration during the neonatal period in rats. Int J Dev Neurosci (2004) 1.03
Learning and memory after neonatal exposure to 3,4-methylenedioxymethamphetamine (ecstasy) in rats: interaction with exposure in adulthood. Synapse (2005) 1.01
Desflurane, isoflurane, and sevoflurane provide limited neuroprotection against neonatal hypoxia-ischemia in a delayed preconditioning paradigm. Anesthesiology (2009) 1.01
Comparison of monoamine and corticosterone levels 24 h following (+)methamphetamine, (+/-)3,4-methylenedioxymethamphetamine, cocaine, (+)fenfluramine or (+/-)methylphenidate administration in the neonatal rat. J Neurochem (2006) 1.00
Methamphetamine exposure during the preweanling period causes prolonged changes in dorsal striatal protein kinase A activity, dopamine D2-like binding sites, and dopamine content. Synapse (2003) 0.99
Ontogeny of the adrenal response to (+)-methamphetamine in neonatal rats: the effect of prior drug exposure. Stress (2006) 0.99
Periadolescent rats (P41-50) exhibit increased susceptibility to D-methamphetamine-induced long-term spatial and sequential learning deficits compared to juvenile (P21-30 or P31-40) or adult rats (P51-60). Neurotoxicol Teratol (2005) 0.99
Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions. Synapse (2005) 0.99
Neurological deficits and glycosphingolipid accumulation in saposin B deficient mice. Hum Mol Genet (2008) 0.99
Alterations in body temperature, corticosterone, and behavior following the administration of 5-methoxy-diisopropyltryptamine ('foxy') to adult rats: a new drug of abuse. Neuropsychopharmacology (2006) 0.98
Effects of neonatal (+)-methamphetamine on path integration and spatial learning in rats: effects of dose and rearing conditions. Int J Dev Neurosci (2008) 0.98
Short- and long-term effects of (+)-methamphetamine and (+/-)-3,4-methylenedioxymethamphetamine on monoamine and corticosterone levels in the neonatal rat following multiple days of treatment. J Neurochem (2007) 0.97
Phosphodiesterase 1B knock-out mice exhibit exaggerated locomotor hyperactivity and DARPP-32 phosphorylation in response to dopamine agonists and display impaired spatial learning. J Neurosci (2002) 0.97
Specific saposin C deficiency: CNS impairment and acid beta-glucosidase effects in the mouse. Hum Mol Genet (2009) 0.97
(+/-)3,4-Methylenedioxymethamphetamine (MDMA) dose-dependently impairs spatial learning in the morris water maze after exposure of rats to different five-day intervals from birth to postnatal day twenty. Dev Neurosci (2009) 0.96
Age-dependent effects of neonatal methamphetamine exposure on spatial learning. Behav Pharmacol (2007) 0.95
Neonatal (+)-methamphetamine increases brain derived neurotrophic factor, but not nerve growth factor, during treatment and results in long-term spatial learning deficits. Psychoneuroendocrinology (2007) 0.94
Treatment with MDMA from P11-20 disrupts spatial learning and path integration learning in adolescent rats but only spatial learning in older rats. Psychopharmacology (Berl) (2006) 0.94
(+)-Methamphetamine increases corticosterone in plasma and BDNF in brain more than forced swim or isolation in neonatal rats. Synapse (2008) 0.93
Neonatal methamphetamine administration induces region-specific long-term neuronal morphological changes in the rat hippocampus, nucleus accumbens and parietal cortex. Eur J Neurosci (2004) 0.93
3,4-Methylenedioxymethamphetamine administration on postnatal day 11 in rats increases pituitary-adrenal output and reduces striatal and hippocampal serotonin without altering SERT activity. Brain Res (2005) 0.93
Developmental effects of +/-3,4-methylenedioxymethamphetamine on spatial versus path integration learning: effects of dose distribution. Synapse (2007) 0.93
Protein tyrosine phosphatase alpha (PTP alpha) knockout mice show deficits in Morris water maze learning, decreased locomotor activity, and decreases in anxiety. Brain Res (2003) 0.93
Effects of (+)-methamphetamine on path integration and spatial learning, but not locomotor activity or acoustic startle, align with the stress hyporesponsive period in rats. Int J Dev Neurosci (2008) 0.93
Use of modafinil for the treatment of attention deficit/hyperactivity disorder. Ann Pharmacother (2006) 0.92
Isoflurane-delayed preconditioning reduces immediate mortality and improves striatal function in adult mice after neonatal hypoxia-ischemia. Anesth Analg (2007) 0.92
Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain. J Pharmacol Exp Ther (2004) 0.92
Neonatal 3,4-methylenedioxymethamphetamine (MDMA) exposure alters neuronal protein kinase A activity, serotonin and dopamine content, and [35S]GTPgammaS binding in adult rats. Brain Res (2006) 0.91
Effect of a neurotoxic dose regimen of (+)-methamphetamine on behavior, plasma corticosterone, and brain monoamines in adult C57BL/6 mice. Neurotoxicol Teratol (2010) 0.91
In utero and lactational exposure to PCBs in mice: adult offspring show altered learning and memory depending on Cyp1a2 and Ahr genotypes. Environ Health Perspect (2011) 0.90
Abnormal response to stress and impaired NPS-induced hyperlocomotion, anxiolytic effect and corticosterone increase in mice lacking NPSR1. Psychoneuroendocrinology (2010) 0.90
Administration of D,L-fenfluramine to rats produces learning deficits in the Cincinnati water maze but not the Morris water maze: relationship to adrenal cortical output. Neurotoxicol Teratol (2002) 0.89
Tolerance by ringed seals (Phoca hispida) to impact pipe-driving and construction sounds at an oil production island. J Acoust Soc Am (2004) 0.89
Dorsal striatal dopamine depletion impairs both allocentric and egocentric navigation in rats. Neurobiol Learn Mem (2012) 0.89
The LIM homeobox gene Isl1 is required for the correct development of the striatonigral pathway in the mouse. Proc Natl Acad Sci U S A (2013) 0.89
Comparison of time-dependent effects of (+)-methamphetamine or forced swim on monoamines, corticosterone, glucose, creatine, and creatinine in rats. BMC Neurosci (2008) 0.88
MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase. J Neuroimmune Pharmacol (2012) 0.88
Comparison of (+)-methamphetamine, ±-methylenedioxymethamphetamine, (+)-amphetamine and ±-fenfluramine in rats on egocentric learning in the Cincinnati water maze. Synapse (2010) 0.86
Pharmacokinetics of gemcitabine in tumor and non-tumor extracellular fluid of brain: an in vivo assessment in rats employing intracerebral microdialysis. Cancer Chemother Pharmacol (2007) 0.86